Taconic Capital Advisors’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Taconic Capital Advisors’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-350,000	Closed	-$60.5M	–	119
2015 Q1	$60.5M	Buy	+350,000	New	+$51.4M	2.68%	8

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Taconic Capital Advisors's SLXP Position: Q2 2015 in Review

Taconic Capital Advisors sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 350,000 shares — an estimated $60.5M sold.

Taconic Capital Advisors first reported a position in SLXP in Q1 2015 and held it in 1 quarter. The position peaked at $60.5M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Taconic Capital Advisors reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Taconic Capital Advisors sold 350,000 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $60.5M.
Taconic Capital Advisors first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q1 2015 and held it in 1 quarter.
Taconic Capital Advisors's SALIX PHARMACEUTICALS LTD DEL position peaked at $60.5M in Q1 2015.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Taconic Capital Advisors's 13F filing for Q2 2015, filed 13 Aug 2015.